Taysha Gene Therapies Inc. (TSHA) Social Stream
Taysha Gene Therapies Inc (TSHA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Taysha Gene Therapies Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
TSHA's average price target has moved down $4.02 over the prior 38 weeks.
Over the past 49 weeks, TSHA's average upside potential has been 182.9%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
TSHA Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
TSHA's average broker recommendation rating improved by 0.03 over the prior 90 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TSHA as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, Taysha Gene Therapies Inc's upside potential (average analyst target price relative to current price) is higher than 581.12% of them.
- In terms of how Taysha Gene Therapies Inc fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 597.72% of that group.
- TSHA has a greater average analyst price target than 499.02% of stocks in the small market cap category.
- In terms of how Taysha Gene Therapies Inc fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than -383.88% of that group.
Make investment decisions regarding TSHA using the data that counts. Try POWR Ratings for free.